This website uses cookies

This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy.

Groups

Dr. rer. nat. Hanns-Joachim Rziha:

Publications

______________________________________________________________________________________________________________________________________________________________________________________________________

Selected publications

 

Hanns-Joachim Rziha, Jörg Rohde, and Ralf Amann. Generation and Selection of Orf Virus (ORFV) Recombinants Methods Mol. Biol. 2016,  p. 177-200. doi: 10.1007/978-1-4939-3008-1_12.(book chapter)

Rohde J, Amann R, Rziha HJ. New Orf Virus (Parapoxvirus) Recombinant Expressing H5 Hemagglutinin Protects Mice against H5N1 and H1N1 Influenza A Virus. PLoS One. 20;8(12):e83802; 2013. 

Amann R, Rohde J, Wulle U, Conlee D, Raue R, Martinon O, Rziha HJ. A new rabies vaccine based on a recombinant ORF virus (parapoxvirus) expressing the rabies virus glycoprotein. J Virol. 87(3):1618-30; 2013.

Rohde, J., Schirrmeier, H., Granzow, H. and H.-J. Rziha. A new recombinant Orf virus (ORFV, Parapoxvirus) protects rabbits against lethal infection with rabbit hemorrhagic disease virus (RHDV). Vaccine 29, 9256-9264; 2011.

van Rooij, E.M.A., Rijsewijk, F.A.M., Moonen-Leusen, H.W., Bianchi, A.T.J. and H.-J. Rziha. Comparison of different prime-boost regimes with DNA and recombinant Orf virus based vaccines expressing glycoprotein D of pseudorabies virus in pigs. Vaccine 28, 1808-1813; 2010.

Grabowska, A.K., Lipinska, A.D., Rohde, J., Szewczyk, B, Bienkowska-Szewczyk, K. and H.-J. Rziha. New baculovirus recombinants expressing Pseudorabies virus (PRV) glycoproteins protect mice against lethal challenge infection. Vaccine 27, 3584-3591; 2009.

Dory, D., T. Fischer, V. Beven, R. Cariolet, H.-J. Rziha and A. Jestin. Prime-boost immunization using DNA vaccine and recombinant Orf virus protects pigs against Pseudorabies virus (Herpes suid 1). Vaccine 24, 6256-6263; 2006.

Hausmann, J., A. Pagenstecher, K. Baur, H.-J. Rziha and P. Staeheli. CD8 T cells require gamma interferon to clear Borna disease virus from the brain and prevent immune system-mediated neuronal damage. J. Virol. 79, 13509-13518; 2005.

Henkel, M., Planz, O., Fischer, T., Stitz, L. and H.-J. Rziha. Prevention of virus persistence and protection against immunopathology after Borna disease virus infection of the brain by a novel Orf virus recombinant. J. Virol. 79, 314-325; 2005.

Fischer, T., O. Planz, L. Stitz and H.-J. Rziha. Novel recombinant Parapoxvirus vectors induce protective humoral and cellular immunity against lethal herpesvirus challenge infection in mice. J. Virol. 77, 9312-9323; 2003.

Rziha, H.-J., M. Henkel, R. Cottone, B. Bauer, U. Auge, F. Götz, E. Pfaff, Röttgen, M., Dehio, C. and M. Büttner. Generation of recombinant parapoxviruses: Non-essential genes suitable for insertion and expression of foreign genes. J. Biotechnol., 83, 137-145; 2000.

Meyer, M., C. Lanz, M. Clauss, A. Lepple-Wienhaus, J. Waltenberger, H.G. Augustin, M. Ziche, M. Büttner, H.-J. Rziha and C. Dehio. A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling by VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinase. EMBO J. 18, 363-374; 1999.